Jim Cramer Explains Why He Added Hinge Health (HNGE) to His Fantasy Lineup
What it means
- What to watch: Policy moves the whole healthcare aisle; trial data moves one company. Knowing which kind of story this is helps.
- How the stock is trading: $HNGE +1.91% in the latest session.
- Timing: Weekend news: the change beside it is Friday's, and Monday's open is the first session that gets a say. Market holidays are not detected.
Where the stock stands
$HNGE last traded at $116.50, +1.91% on the session. That puts it 2.0% shy of its 52-week high of $118.86 and 287% clear of its low of $30.08 — within a tenth of its 52-week high. Over the year it has ranged 295% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $HNGE page.
How much coverage it is getting
In the last 30 days Wook has filed 4 stories about $HNGE — 2 of them this week. At its 30-day pace you would expect about 1 a week, so this week is running well ahead of normal — something has the newsroom's attention. Across those stories 4 read bullish, 0 neutral and 0 bearish. This one reads neutral, so it sits in a small minority of the run. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$HNGE earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
For the receipts, the $HNGE page has the full chart, the filings and the valuation model these figures come from. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $HNGE sits from its high, or how this week's coverage stacks up.
How this analysis was made
Yahoo Finance published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $HNGE. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Yahoo Finance published this on September 12, 2026. $HNGE has moved +22.90% ($94.79 to $116.50). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.